A SPAC I to merge with Asian fertility products and services supplier NewGenIVF (NASDAQ:ASCA)

photo on spac (special purpose acquisition company) theme. wooden cubes with the abbreviation

Ivan Martynov

A SPAC I Acquisition Corp. (NASDAQ:ASCA) plans to merge with Southeast Asian fertility products and services supplier NewGenIVF.

The deal, which is anticipated to near in Q3, estimates NewGenIVF’s undertaking worth at round $50M. Stocks of the mixed corporate are expected to business on Nasdaq.

NewGenIVF gives complete fertility therapies and products and services, together with egg/sperm donation and surrogacy, via its clinics based totally in Thailand, Cambodia and Kyrgyzstan. 

A SPAC I went public in February 2022, elevating $60M. 


Risk Warning: 74-89% of retail investor accounts lose money when trading CFDs . You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money